Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul;28(7):2367-2371.
doi: 10.1111/ene.14816. Epub 2021 Mar 26.

No increased suggestibility to placebo in functional neurological disorder

Anne-Catherine M L Huys  1 , Brianna Beck  2 , Patrick Haggard  3 , Kailash P Bhatia  1 , Mark J Edwards  4
Affiliations
Case Reports

No increased suggestibility to placebo in functional neurological disorder

Anne-Catherine M L Huys et al. Eur J Neurol. 2021 Jul.

Abstract

Background and purpose: On the basis of occasional strong placebo responses, increased susceptibility to placebo has been proposed as a characteristic of functional neurological disorder (FND). The aim of this study was to clarify whether people with FND have a stronger placebo analgesic response than healthy controls.

Methods: A study using a classic placebo paradigm, with additional conditioning and open-label components, was performed in 30 patients with FND, and in 30 healthy controls. Ratings of mildly to moderately painful electrotactile stimuli were compared before and after the application of a placebo "anaesthetic" cream versus a control cream, after an additional conditioning exposure, and after full disclosure (open-label component).

Results: Pain intensity ratings at the placebo compared to the control site were similarly reduced in both groups. The conditioning exposure had no additional effect. After placebo disclosure a residual analgesic effect remained.

Conclusion: Patients with FND did not have stronger placebo responses than healthy controls. The notion of generally increased suggestibility or increased suggestibility to placebo in FND seems mistaken. Instead, occasional dramatic placebo responses may occur because functional symptoms are inherently more changeable than those due to organic disease.

Keywords: conversion disorder; functional neurological disorder; open-label placebo; pain; placebo; suggestibility.

PubMed Disclaimer

References

REFERENCES

    1. Charcot J-M, Marie P. Hysteria mainly hystero-epilepsy. In: A dictionary of psychological medicine. Churchill, J A; 1892. p. 627-41.
    1. Janet P. The Major Symptoms of Hysteria. London: MacMillan; 1907.
    1. Roelofs K, Hoogduin KAL, Keijsers GPJ, Näring GWB, Moene FC, Sandijck P. Hypnotic susceptibility in patients with conversion disorder. J Abnorm Psychol. 2002;111(2):390-395.
    1. Foong J, Lucas PA, Ron MA. Interrogative suggestibility in patients with conversion disorders. J Psychosom Res. 1997;43(3):317-321.
    1. Eysenck HJ. Suggestibility and hysteria. J Neurol Neurosurg Psychiatry. 1943;6(1-2):22-31.

Publication types

LinkOut - more resources